Loading...
OTC Markets
Totals
Securities
12,222
Dollar Vol
$2.4B
Share Vol
3.3B
Trades
373,306

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

AGNPF
Algernon Pharmaceuticals Inc.

Ordinary Shares

0.036

0.00

0.00%

0.04 / 0.0524 (125000 x 25000)

Real-Time Best Bid & Ask: 05:00pm 07/21/2025
Delayed (15 Min) Trade Data: 12:00am 07/18/2025

0.00

N/A

0

Market Cap calculated only for this class of securities.

1,231,460

Real-Time Level 2 Quote
Trade Data
News
Filings and Disclosure
Company Description
Algernon Pharmaceuticals Inc. Company Logo
Algernon Pharmaceuticals is a Canadian healthcare company pioneering the establishment of Alzheimer’s screening, imaging and treatment medical clinics in North America, while also advancing clinical stage pharmaceuticals through the investigation of multiple drugs for unmet global medical needs. Algernon Pharmaceuticals is also the parent company of a private subsidiary called Algernon NeuroScience, that is advancing a psychedelic program investigating a proprietary form of DMT for stroke and traumatic brain injury.
Videos
OTCQB Venture Market Logo
Joined OTCQB 05/2016
The Company Profile data was verified by the issuer within the previous 6 months.
This company has certified to OTC Markets Group that it is eligible to rely on the exemption from registration under Securities and Exchange Act Rule 12g3-2(b).
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.